Literature DB >> 1682374

Fluconazole and Candida krusei infections.

G E Bignardi, M A Savage, R Coker, S G Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1682374     DOI： 10.1016/0195-6701(91)90193-c

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  5 in total

Review 1.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

2.  Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.

Authors:  K Venkateswarlu; D W Denning; N J Manning; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

3.  In vitro and in vivo antifungal activities of D0870, a new triazole agent.

Authors:  H Yamada; T Tsuda; T Watanabe; M Ohashi; K Murakami; H Mochizuki
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 4.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 5.  Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients.

Authors:  K L Goa; L B Barradell
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.